Break Up Big Medicine Act
Analysis under review: This bill has generated analysis that may be too generic or incomplete. Clause-level evidence remains available below.
Summary
What This Bill Does
This bill, Break Up Big Medicine Act, changes federal law or congressional policy affecting health care providers and patients. The main policy domain is Healthcare, Government Operations, Trade.
Who Benefits and How
health care providers and patients may benefit from new authority, funding, eligibility, regulatory clarity, or reduced risk created by the bill.
Who Bears the Burden and How
federal implementing agencies, health care providers and patients may take on implementation duties, reporting obligations, compliance costs, or oversight responsibilities.
Key Provisions
- Section S1: 1. Short title This Act may be cited as the Break Up Big Medicine Act.
- Section id9199386174ae422f8c0f23f836406397: 2. Findings The Congress finds the following: Large, vertically integrated health care platforms dominate the American health care system. These corporate...
- Section idf07010be611745ba844794ca8b1b9074: 3. Prohibitions relating to anticompetitive ownership and contracts It shall be unlawful for any person to both— directly or indirectly own, operate, control,...
Evidence Chain:
This summary is generated from the full bill text using AI analysis. Expand "Detailed Analysis" below for identified beneficiaries/burden bearers with clause-level evidence links.
At a Glance
What This Bill Does
This bill, Break Up Big Medicine Act, changes federal law or congressional policy affecting health care providers and patients.
Key Policy Areas
Healthcare, Government Operations, Trade
Primary Purpose
This bill, Break Up Big Medicine Act, changes federal law or congressional policy affecting health care providers and patients.
Policy Domains
Whole bill
Identified Gains
- health care providers and patients
Identified Costs
- federal implementing agencies
- health care providers and patients
Sponsors
Legislative Progress
In CommitteeRead twice and referred to the Committee on the Judiciary.
Introduced in Senate
Ms. Warren (for herself and Mr. Hawley) introduced the following …
Impact analysis is available but no clear stakeholder effects identified. View clause-level analysis →
Bill Structure & Actor Mappings
Who is "The Secretary" in each section?
- "the_commission"
- → The commission identified in the operative section
We use a combination of our own taxonomy and classification in addition to large language models to assess meaning and potential beneficiaries. High confidence means strong textual evidence. Always verify with the original bill text.
Learn more about our methodology